Fabiola Schafer

Fabiola Schafer

Auto-generated profile, based on publicly available information

Fabiola Schafer

Department of Medical Specialties, School of Medicine, Universidad de La Frontera, Temuco, Chile

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2013 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
FSFabiola Schafer
Fabiola Schafer
FFFelix Fich
Felix Fich
MLMarusella Lam
Marusella Lam
CGCynthia Gárate
Cynthia Gárate
AWAniela Wozniak
Aniela Wozniak
PGPatricia Garcia
Patricia Garcia

Verified
Journal Article
Open access
PDF file
DLDaniela León
Daniela León
KBKurt Buchegger
Kurt Buchegger
RSRamón Silva
Ramón Silva
Ismael RiquelmeIsmael Riquelme
Ismael Riquelme
TVTamara Viscarra
Tamara Viscarra
PBPriscilla Brebi
Priscilla Brebi
Photodynamic therapy (PDT) has been used to treat certain types of non-melanoma skin cancer with promising results. However, some skin lesions have not fully responded to this treatment, suggesting a potential PDT-resistant phenotype. Therefore, novel therapeutic alternatives must be identified that improve PDT in resistant skin cancer. In this study, we analyzed the cell viability, intracellular protoporphyrin IX (PpIX) content and subcellular localization, proliferation profile, cell death, reactive oxygen species (ROS) detection and relative gene expression in PDT-resistant HSC-1 cells. PDT-resistant HSC-1 cells show a low quantity of protoporphyrin IX and low levels of ROS, and thus a low rate of death cell. Furthermore, the resistant phenotype showed a downregulation of HSPB1, SLC15A2, FECH, SOD2 and an upregulation of HMBS and BIRC5 genes. On the other hand, epigallocatechin gallate catechin enhanced the MAL-PDT effect, increasing levels of protoporphyrin IX and ROS, and killing 100% of resistant cells. The resistant MAL-PDT model of skin cancer squamous cells (HSC-1) is a reliable and useful tool to understand PDT cytotoxicity and cellular response. These resistant cells were successfully sensitized with epigallocatechin gallate catechin. The in vitro epigallocatechin gallate catechin effect as an enhancer of MAL-PDT in resistant cells is promising in the treatment of difficult skin cancer lesions.

1 August 2013 in Revista médica de Chile
Verified
Journal Article
Open access
PDF file
CPCarlos Pastor
Carlos Pastor
GBGastón Briceño
Gastón Briceño
FSFabiola Schafer
Fabiola Schafer

13 November 2013 in Archives of Disease in Childhood - Fetal and Neonatal Edition
Verified
Journal Article
Closed access
PDF file
FSFabiola Schafer
Fabiola Schafer
MTMarcos Tapia
Marcos Tapia
CPCristian Pinto
Cristian Pinto

13 July 2022 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
FSFabiola Schafer
Fabiola Schafer
RMRodrigo Miranda
Rodrigo Miranda

8 May 2014 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
CPCristian Pinto
Cristian Pinto
MLMauricio Lechuga
Mauricio Lechuga
EBEnrique Bellolio
Enrique Bellolio
SGSergio Gonzalez
Sergio Gonzalez
FSFabiola Schafer
Fabiola Schafer